Feedback / Questions
IkT-148009 - Inhibikase, Clintrex
https://www.prnewswire.com/news-releases/inhibikase-therapeutics-announces-dosing-of-first-parkinsons-patient-in-its-phase-1b-clinical-trial-of-ikt-148009-301402749.html
Oct 19, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next